Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2015 2
2016 2
2017 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Oral Antibiotic Transition in Patients with Bacteremia with a Urinary Source Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli.
Noguchi T, Shinohara K, Tsuchido Y, Yukawa S, Yamamoto M, Matsumura Y, Hayashi M, Yamada Y, Hayashi A, Shimizu T, Nagao M. Noguchi T, et al. Among authors: hayashi a. Jpn J Infect Dis. 2022 Mar 24;75(2):205-208. doi: 10.7883/yoken.JJID.2020.1084. Epub 2021 Aug 31. Jpn J Infect Dis. 2022. PMID: 34470959 Free article.
Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia.
Matsumura Y, Yamamoto M, Nagao M, Komori T, Fujita N, Hayashi A, Shimizu T, Watanabe H, Doi S, Tanaka M, Takakura S, Ichiyama S. Matsumura Y, et al. Among authors: hayashi a. Antimicrob Agents Chemother. 2015 Sep;59(9):5107-13. doi: 10.1128/AAC.00701-15. Epub 2015 Jun 22. Antimicrob Agents Chemother. 2015. PMID: 26100708 Free PMC article.
Impact of industrial structure and soil exposure on the regional variations in pulmonary nontuberculous mycobacterial disease prevalence.
Hamada S, Ito Y, Hirai T, Murase K, Tsuji T, Fujita K, Mio T, Maekawa K, Fujii T, Ono S, Nishimura T, Hayashi A, Komori T, Fujita N, Niimi A, Ichiyama S, Chin K, Mishima M. Hamada S, et al. Among authors: hayashi a. Int J Mycobacteriol. 2016 Jun;5(2):170-6. doi: 10.1016/j.ijmyco.2016.02.006. Epub 2016 Mar 8. Int J Mycobacteriol. 2016. PMID: 27242228 Free article.
Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
Matsumura Y, Yamamoto M, Higuchi T, Komori T, Tsuboi F, Hayashi A, Sugimoto Y, Hotta G, Matsushima A, Nagao M, Takakura S, Ichiyama S. Matsumura Y, et al. Among authors: hayashi a. Int J Antimicrob Agents. 2012 Aug;40(2):158-62. doi: 10.1016/j.ijantimicag.2012.04.013. Epub 2012 Jun 27. Int J Antimicrob Agents. 2012. PMID: 22743014 Free article.
Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group. Matsumura Y, et al. J Antimicrob Chemother. 2012 Nov;67(11):2612-20. doi: 10.1093/jac/dks278. Epub 2012 Jul 26. J Antimicrob Chemother. 2012. PMID: 22843833 Free article.
CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
Matsumura Y, Johnson JR, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S; Kyoto–Shiga Clinical Microbiology Study Group; Kyoto-Shiga Clinical Microbiology Study Group. Matsumura Y, et al. J Antimicrob Chemother. 2015;70(6):1639-49. doi: 10.1093/jac/dkv017. Epub 2015 Feb 16. J Antimicrob Chemother. 2015. PMID: 25687644